洪博培癌症 Institute highlights two examples of clinical trials at HCI exploring new innovations in cancer, including the I-SPY2 trial, studying new approaches for breast cancer treatment, 和SWOG...
A study published today in the Journal of Clinical Oncology expands on evidence of lower health care costs and fewer unplanned health care visits in an acute care model of...
研究ers at 洪博培癌症 Institute have found critical new insights into how cells defend against melanoma. In a report published in Nature Communications, the team describes how an enzyme called...
Siqi胡, 博士学位, is a member of the Hashibe Lab at 洪博培癌症 Institute. Hu presented results at the 2021 virtual American Association for Cancer 研究 Annual Meeting that women...
Utah had more melanoma deaths than any other state from 1975 to 2013, says a letter published today by HCI researchers in the New England Journal of Medicine. 与此形成鲜明对比的是...
每5到7年一次, HCI goes through a rigorous application process to maintain status as a National Cancer Institute-Designated Comprehensive Cancer Center and prove we meet the highest national...
The Accelerator at the University of Utah, headed by Dr. 大卫·贝尔斯——, is working in conjunction with the 洪博培癌症 Institute, 药学院, and the Partners for Innovation...
2020年3月, COVID-19 led to restrictions in on-site activities at HCI, at the University of Utah, 横跨整个州, and throughout the nation. HCI researchers were determined to keep...
Clinical trials bring hope to patients in the form of innovative treatments. During the COVID-19 pandemic, despite strict hospital safety protocols and staff switching to remote work, HCI临床研究...
When cancer researchers from different disciplines work together, they gain new insights into how cancer begins and how it can be treated. HCI is committed to providing an atmosphere where...
洪博培癌症 Institute is dedicated to creating an environment that not only promotes—but insists upon—equity, 多样性, 和包容. Read highlights of noteworthy programs and research from the Cancer Control and...
An international group of cancer clinical research experts reported new recommendations that receiving a COVID-19 vaccination should not preclude a cancer patient from participating on a clinical trial. 洪博培癌症...
HCI physician-scientist Ami Patel, MD, has been selected by the American Society of Hematology (ASH) to receive a Scholar Award for her research in leukemia. ASH Scholar Awards are one...
"Any human disease is so complicated that in order to really have the best care for patients, as well as sort of pushing the envelope on research, 你需要专家...
洪博培癌症 Institute at the University of Utah announces the appointment of four new members to its External Advisory Board: Olufunmilayo Olopade, MD, 詹妮弗Pietenpol, 博士学位, 列奥尼达C. 马里兰州Platanias...